Vigilance Workbench Platform
The Vigilance Workbench signal detection platform spans the full spectrum of the signal management process to ensure all potential signals are tracked with clear prioritization. Robust data integration and functionality enables analysis of aggregate data from multiple adverse event datasets, supported by configurable planning and workflow capabilities.
Safety and Pharmacovigilance Operations
Qinecsa provides complete and compliant safety and pharmacovigilance frameworks to support clinical and commercial products.
Global Medical Information Call Center
Qinecsa provides industry-leading medical and safety call center services led by our team of highly experienced specialists. Our teams provide support covering a diverse range of therapeutic areas. A multi-channel technology enables our team to accept medical information, adverse event, and product quality calls in a variety of languages across the globe.
Join Qinecsa at Virtue Insights 34th Pharmacovigilance UK & EU 2024
Qinecsa’s team of experts is looking forward to connecting with you at the Virtue Insights 34th Pharmacovigilance UK & EU 2024 to explore the latest developments in pharmacovigilance, drug safety & risk management. Attend Humaira Qureshi’s presentation:‘Ushering in a New Era for Pharmacovigilance‘12:20pm Tuesday 30 January Click here to meet with our experts and learn […]
Join Qinecsa at DIA Global Pharmacovigilance and Risk Management Strategies Conference
Qinecsa’s team of experts is looking forward to connecting with you at the DIA Global Pharmacovigilance and Risk Management Strategies Conference 2024. DIA’s Global Pharmacovigilance and Risk Management Strategies Conference is developed by regulators and industry experts to discuss the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety professionals. Visit […]
Qinecsa appoints John Freeman JD, M.Sc., B.Sc. to the Board of Directors
Announcement – 14th December 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of John Freeman JD, M.Sc., B.Sc. as Non-executive Director. With a background in Clinical Pharmacology and Law, John has held prominent global leadership roles in pharmacovigilance and risk management. He has worked in the field of pharmacovigilance since […]
Launching the next-generation Literature Management solution
Announcement – Qinecsa Solutions Launches Next-Generation Literature Management Solution in Collaboration with AAICO, Revolutionizing Pharmacovigilance with AI London, December 13, 2023 – Qinecsa Solutions, experts in technology-driven end-to-end pharmacovigilance solutions, proudly announces the launch of its latest literature management solution in partnership with The Applied AI Company (AAICO). This strategic union combines Qinecsa’s medical […]
Join Qinecsa at J.P. Morgan Healthcare Conference 2024
Qinecsa is on a mission to drive positive change in the pharmacovigilance industry. As we enter a new year with exciting plans to continue advancing pharmacovigilance solutions, we look forward to engaging with industry leaders and investors at the forefront of healthcare innovation. Meet John Gillie, Qinecsa CEO at the event to explore the potential […]
Qinecsa appoints Arthur Shih as General Counsel
6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur Shih as General Counsel. With over 25 years in private practice and in-house leadership roles, Arthur brings extensive international legal and commercial experience to support the execution of Qinecsa’s future growth strategy. “Qinecsa is a market-leader […]
Introducing the Qinecsa PV Insights Network: Connecting peers for practical drug safety solutions
Empowering leaders in small pharma and biotech with responsibility for drug safety We are thrilled to announce the launch of the Qinecsa PV Insights Network, an initiative designed specifically for pharmacovigilance (PV) leaders in small pharma and biotech companies who bear the critical responsibility of drug safety. Following the overwhelming response to a series of […]
